Synapsoft logo
AI Insights from Disclosures
Searching...
VUNO, Inc. 338220
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
VUNO, Inc. is recognized as a market pioneer that introduced deep learning into Korea's medical IT field and achieved actual commercialization, and it pioneered Korea's artificial intelligence medical device market in 2018 by launching 'VUNO Med-BoneAge', the country's first AI medical device. Based on its unique deep learning technology, the company has grown into a company that learns from and analyzes a wide range of medical data, including biosignals and medical images (X-rays, CT, MRI, fundus images, etc.), and leads innovation across the entire medical field, spanning diagnosis to prognosis and prediction.
Representative Director Lee Yeha
Founded December 10, 2014
Corporation Type KOSDAQ
Industry Classification Software publishing
Corporate number 13481-0319279
Business number 135-86-50644
Phone Number 02-515-6646
Fax Number 02-515-6647
Website www.vuno.co
Company Address 479 Gangnam-daero, Seocho-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant